ALITZA FORD: Open Payments
NPI 1356346886 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 29 payments from 16 companies in 2025. Trend: 2023 $1,782 · 2024 $1,470 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| Ardelyx, Inc. | 2 | $53 |
| Celltrion USA Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 4 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Madrigal Pharmaceuticals | 2 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
Products named: LINZESS, IBSRELA, VEGZELMA, GATTEX, OMVOH, XIFAXAN, VOQUEZNA, DUPIXENT.
Industry payments across TX — which companies pay providers there.
